The global intraoperative radiation therapy systems market is anticipated to reach US$ 55.9 million by 2022. IORT is the administration of therapeutic stages of radiation to the cancer location. Along with outer beam radiation, chemotherapy, and surgery, IORT is widely utilised in the multimodal treatment of privately advanced and recurrent disease.
As of late, IORT has been used to treat early stage disorders like as breast cancer growth and prostate cancer. Between 2022 and 2032, the global demand for intraoperative radiation treatment systems is predicted to grow at a 7.7% CAGR, reaching roughly US$ 126.8 million.
Get Full PDF Sample Copy of Latest Report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-5180
Regional Insights:
The North American intraoperative radiation treatment systems market is anticipated to reach 36.4% by 2022. Because of improved knowledge and reports of breast cancer rates, the United States has a major proportion in North America.
The easy availability and high adoption of IORT for cancer treatment, as well as significant per capita annual healthcare expenditure in the US and Canada, are major factors driving market growth in this region. In addition to this, the American Society for Radiation Oncology (ASTRO) has advocated the use of low-energy IORT, which has contributed to its increased adoption in North America.
Competitive Landscape:
Prominent players in the Intraoperative Radiation Therapy Systems market IntraOp Medical, Inc., Ariane Medical Systems Ltd, Varian Medical Systems, Inc., Carl Zeiss AG, Eckert & Ziegler, Sensus Healthcare, iCAD Inc., Elekta AB, SIT – S.I.T. Sordina IORT Technologies S.p.A., REMEDI Co.,Ltd., GMV, Brainlab AG, and others.
- In April 2021 Varian Medical Systems, Inc. struck an agreement with Australia’s Icon Group to supply 30 linear accelerators and accompanying treatment software to combat the worldwide cancer burden. This will assist the company in expanding access to care in regional and underserved areas of Australia and Asia.
- In October 2020 IntraOp Medical, Inc. and the University of Verona in Italy announced the enrolment of their first patient in the PancFORT Study. This has aided the company in furthering the research and clinical evidence supporting the significance of IORT in cancer treatment.
Last few days to get reports at discounted prices, offer expires soon!
Request Discount@ https://www.futuremarketinsights.com/request-discount/rep-gb-5180
More Insights Available
Europe is expected to be the second-largest intraoperative radiation therapy market due to the increasing prevalence of cancer, growing geriatric population, and favorable reimbursement policies in the region. The Asia-Pacific market is expected to witness significant growth during the forecast period due to the increasing incidence of cancer, growing healthcare expenditure, and rising awareness about intraoperative radiation therapy in the region.
Segmentation
The report provides insights on the important highlights and current trends prevailing in the market. This helps the readers to gain a deeper understanding and form an unbiased opinion on the market. Numerous segmentations have been provided for this market based on:
Segmentation based on Disease Indication:
- Brain Tumors
- Breast Cancer
- Gastrointestinal Tumors
- Head & Neck Tumors
- Skin Cancer
- Spinal Metastases
- Others
Segmentation based on End User
- Hospitals
- Specialty Clinics
- Ambulatory & Surgical Centers
- Others
For more report customization, connect with us@ https://www.futuremarketinsights.com/customization-available/rep-gb-5180
Full in-depth analysis of the parent market
The analysts at FMI are dedicated to provide insights after extensive research and study. The study also includes estimations, projections and evaluation of the market dynamics.
Important changes in market dynamics
The report has been created after detailed and exhaustive studies by the analysts at FMI taking several factors into consideration like monetary, ecological, social, mechanical, and political status of a particular demography. They study the key data to assess the revenue and production of manufacturers across various regions. The report also covers an in-depth analysis of the key changes in market dynamics in the recent past and the near future.
About Future Market Insights, Inc.
Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.
Contact:
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs